Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting | Zendy

Rudolph M. Navari | Zendy; Rui Qin | Zendy; Kathryn J. Ruddy | Zendy; Heshan Liu | Zendy; Steven Powell | Zendy; Madhuri Bajaj | Zendy; Leah L. Dietrich | Zendy; David D. Biggs | Zendy; Jacqueline M. Lafky | Zendy; Charles L. Loprinzi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting

Author(s) -

Rudolph M. Navari,

Rui Qin,

Kathryn J. Ruddy,

Heshan Liu,

Steven Powell,

Madhuri Bajaj,

Leah L. Dietrich,

David D. Biggs,

Jacqueline M. Lafky,

Charles L. Loprinzi

Publication year - 2016

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1515725

Subject(s) - olanzapine , medicine , nausea , placebo , vomiting , aprepitant , chemotherapy , chemotherapy induced nausea and vomiting , anesthesia , antiemetic , dopamine antagonist , concomitant , gastroenterology , antagonist , schizophrenia (object oriented programming) , alternative medicine , receptor , pathology , psychiatry

We examined the efficacy of olanzapine for the prevention of nausea and vomiting in patients receiving highly emetogenic chemotherapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research